Enoxaparin dosage forms and strengths

Revision as of 03:10, 6 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Enoxaparin}} {{CMG}}; {{AE}} {{SS}} ==Dosage Forms And Strengths== Lovenox is available in two concentrations: ===100 mg/mL Concentration=== {| |- |File:ENOXA...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Enoxaparin
LOVENOX® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Enoxaparin
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Dosage Forms And Strengths

Lovenox is available in two concentrations:

100 mg/mL Concentration

150 mg/mL Concentration

-Graduated Prefilled Syringes 120 mg/0.8 mL, 150 mg/1 mL[1]

References

  1. "LOVENOX (ENOXAPARIN SODIUM) INJECTION [SANOFI-AVENTIS U.S. LLC]". Retrieved 6 February 2014.

Template:WikiDoc Sources